Living With an Invisible Illness

Chronic illness often remains invisible to others, creating significant challenges for those living with long-term health conditions, according to recent Dutch research and patient testimonies highlighting the gap between internal experience and external perception.

A 2024 survey conducted by the Netherlands Institute for Health Services Research (NIVEL) found that over 60 percent of adults living with chronic conditions such as fibromyalgia, lupus, multiple sclerosis, and long COVID reported that others frequently doubted the severity of their illness because they appeared physically well. The study, which included responses from more than 4,500 participants across the Netherlands, underscored a widespread phenomenon where symptoms like fatigue, pain, and cognitive dysfunction are not visibly apparent, leading to misunderstanding in personal, professional, and medical settings.

One participant, a 34-year-old woman diagnosed with systemic lupus erythematosus, shared her experience in a follow-up interview published by the Dutch health news outlet story.nl: “Niemand ziet aan mij dat ik ziek ben,” which translates to “No one can see that I am sick just by looking at me.” She described how, despite managing daily pain levels that often require medication and rest, she faces skepticism when requesting accommodations at work or explaining cancellations to friends. Her testimony reflects a broader pattern documented in the NIVEL study, where nearly half of respondents said they had avoided disclosing their condition due to fear of not being believed.

Medical professionals note that this disconnect between appearance and symptom burden is particularly common in autoimmune and neurological disorders. Dr. Elise van der Meer, a rheumatologist at Amsterdam University Medical Centers, explained that conditions like lupus and fibromyalgia involve systemic inflammation and central sensitization processes that do not produce outward signs such as rashes, swelling, or mobility aids in all cases. “A patient may look perfectly healthy while experiencing debilitating fatigue or widespread pain that impacts their ability to function,” she said. “When clinicians or employers rely solely on observable signs, they risk underestimating the functional impact of the disease.”

The invisibility of symptoms also affects access to disability benefits and workplace accommodations. In the Netherlands, eligibility for certain support programs often requires medical documentation that demonstrates functional limitations. However, as noted in a 2023 report by the Dutch Social Insurance Bank (SVB), assessors sometimes place undue weight on physical appearance during evaluations, particularly for conditions lacking standardized biomarkers or visible progression. Advocacy groups such as the Dutch Chronic Illness Alliance (Nederlandse Chronisch Zieken Alliantie) have called for training programs that help evaluators recognize non-visible symptoms and understand the fluctuating nature of many chronic illnesses.

Research published in the journal BMC Public Health in 2023 supports these concerns, finding that individuals with non-visible chronic conditions reported higher rates of workplace discrimination and social isolation compared to those with more outwardly apparent disabilities. The study, which analyzed data from over 8,000 European respondents, concluded that lack of visibility contributes to delayed help-seeking, reduced self-advocacy, and increased psychological distress, including symptoms of anxiety and depression.

Efforts to address this issue include public awareness campaigns and clinical tools designed to improve recognition of invisible symptoms. In 2022, the Dutch Ministry of Health launched the “Zichtbaar Onzichtbaar” (Visible Invisible) initiative, which uses patient narratives and educational materials to inform employers, educators, and healthcare providers about conditions that do not present with obvious physical signs. The program emphasizes the importance of listening to patient-reported outcomes and using standardized questionnaires such as the Patient-Reported Outcomes Measurement Information System (PROMIS) to assess symptom burden objectively.

Experts caution that while awareness is growing, systemic changes are needed to ensure equitable treatment. “We must move beyond judging illness by appearance,” said Dr. Van der Meer. “Reliance on visible cues perpetuates inequities and delays care for millions living with conditions that are real, debilitating, and deserving of recognition — even when they cannot be seen.”